Warzee, F., Legrand, V., & Scheen, A. (2004). Angioplastie percutanee coronaire chez le patient diabetique Partie 1 : echecs relatifs lies a la restenose apres angioplastie simple. Revue Médicale de Liège, 59 (10), 584-90. Peer reviewed |
Warzee, F., Legrand, V., & Scheen, A. (2004). Angioplastie percutanee coronaire chez le patient diabetique. Partie 2: Espoirs apportes par les protheses endovasculaires. Revue Médicale de Liège, 59 (11), 653-8. Peer reviewed |
Scheen, A., & Warzee, F. (2004). Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries. Diabetes Care, 27 (7), 1840-1. doi:10.2337/diacare.27.7.1840 Peer Reviewed verified by ORBi |
Warzee, F., Legrand, V., & Scheen, A. (2004). Angioplastie percutanee coronaire chez le patient diabetique. Partie 3: Nouvelles perspectives apportees par les stents enrobes. Revue Médicale de Liège, 59 (12), 711-6. Peer reviewed |
Scheen, A., Warzee, F., & Legrand, V. (2004). Drug-eluting stents: meta-analysis in diabetic patients. European Heart Journal, 25 (23), 2167-8; author reply 2168-9. doi:10.1016/j.ehj.2004.07.041 Peer Reviewed verified by ORBi |
Detry, O., Warzee, F., Polus, M., De Roover, A., Meurisse, M., & Honore, P. (October 2003). Liver resection for noncolorectal, nonneuroendocrine metastases. Acta Chirurgica Belgica, 103 (5), 458-462. doi:10.1080/00015458.2003.11679467 Peer Reviewed verified by ORBi |